Addiction Toxicology Case Conference - April 2021

Addiction Toxicology Case Conference - April 2021

  • Register
    • Non-member - Tier I - Free!
    • Non-member - Tier II - Free!
    • Non-member - Tier III - Free!
    • Non-member - Tier IV - Free!
    • Member - Tier I - Free!
    • Member - Tier II - Free!
    • Member - Tier III - Free!
    • Member - Tier IV - Free!

Case 1
A 31-year-old M with opioid use disorder and extensive history of synthetic cannabinoid dependence re-engages with an outpatient treatment program during COVID-19. He reports, “trouble restarting the Suboxone because of fentanyl,” and that he cannot stop using K2 because he has withdrawal when he does.

Case 2
A 25-year-old M is brought to the ED from jail after turning himself in. His significant other had encouraged him to do so for warrant, partly because he needed to stop using K2 and “sort everything out for a while.” During a search, several balloons containing a substance are discovered and two are recovered by the guards; however, one is grabbed and swallowed by the individual. He is brought to the ED and, shortly after arrival, has a seizure. His UDS is positive for fentanyl and negative for everything else.


Series Moderators

  • Timothy J. Wiegand, MD, FACMT, DFASAM (ACMT/ASAM Expert), Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY  
  • Gloria J. Baciewicz, MD (ASAM Expert), Medical Director, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY

Panelists

  • Erik Gunderson, MD, DFASAM (ASAM Expert) Director, Center for Wellness and Change; Associate Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine, Charlottesville, VA
  • Barry K. Logan, PhD, F-ABFT (Guest Expert) Executive Director, Center for Forensic Science Research and Education, Fredric Rieders Family Renaissance Foundation; Senior Vice President of Forensic Sciences, Chief Scientist, NMS Labs, Willow Grove, PA
  • Michael Weaver, MD, DFASAM (ASAM Expert) Medical Director, Center for Neurobehavioral Research on Addiction; Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX

About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

This webinar is open to the public.

Key:

Complete
Failed
Available
Locked
Addiction Toxicology Case Conference - April 2021
Open to view video.
Open to view video.